Document Detail

Hepatitis A immunization strategies: universal versus targeted approaches.
MedLine Citation:
PMID:  16211195     Owner:  NLM     Status:  MEDLINE    
The alternative to nationwide childhood hepatitis A vaccination is to continue targeting high-risk adults. To consider how many of today's children will become vaccination candidates, the proportion of adults reporting a lifetime history of hepatitis A risk factors was examined. One thousand thirty-four US adults responded to a confidential postal survey, 49% of whom had met current Advisory Committee on Immunization Practices (ACIP) criteria for immunization and 72% had met an expanded set of criteria. Because adult vaccination is more costly per capita, targeted vaccination may provide modest financial savings with none of the benefits associated with reduced child-to-adult transmission.
R Jake Jacobs; Allen S Meyerhoff; Thomas Zink
Related Documents :
17728025 - Role of u.s. military research programs in the development of u.s.-licensed vaccines fo...
11578765 - Vaccination against hepatitis a in children aged 12 to 24 months [corrected].
16707195 - Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant h...
8898425 - Safety and immunogenicity of a combined hepatitis a and hepatitis b vaccine in young he...
2239635 - Measles update.
19432635 - Vaccines for an influenza pandemic: scientific and political challenges.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical pediatrics     Volume:  44     ISSN:  0009-9228     ISO Abbreviation:  Clin Pediatr (Phila)     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-07     Completed Date:  2006-03-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372606     Medline TA:  Clin Pediatr (Phila)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  705-9     Citation Subset:  AIM; IM    
Capitol Outcomes Research, Inc., Alexandria, VA 22310, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis
Cross-Sectional Studies
Hepatitis A / prevention & control*
Hepatitis A Vaccines* / administration & dosage,  economics
Hepatitis A Virus, Human / immunology
Immunization Schedule
Risk Factors
Vaccination / economics*
Reg. No./Substance:
0/Hepatitis A Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human bites and blood exposures in New York City schools.
Next Document:  Screening for hypertension in high school.